Published in Circ Cardiovasc Genet on April 25, 2016
Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III. J Am Coll Cardiol (2017) 0.78
The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study. Diabetologia (2017) 0.75
The human genome browser at UCSC. Genome Res (2002) 168.23
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA (2007) 11.98
Cohort Profile: the 'children of the 90s'--the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol (2012) 11.79
Discovery and refinement of loci associated with lipid levels. Nat Genet (2013) 7.86
A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc (2009) 5.81
Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med (2012) 5.80
Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47
Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol (2012) 5.12
Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health (2003) 4.67
Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. N Engl J Med (2014) 4.41
Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet (2012) 4.08
GWAF: an R package for genome-wide association analyses with family data. Bioinformatics (2009) 3.81
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00
High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst (2009) 2.49
Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans. Circ Res (2013) 2.41
Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol (2010) 2.17
Targeting APOC3 in the familial chylomicronemia syndrome. N Engl J Med (2014) 2.06
Triglycerides and cardiovascular disease. Lancet (2014) 2.04
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia. N Engl J Med (2015) 2.03
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest (1986) 1.96
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clin Sci (Lond) (2008) 1.85
Long-term leisure-time physical activity and serum metabolome. Circulation (2012) 1.81
Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes (2012) 1.80
Direct visualization of lipid deposition and reverse lipid transport in a perfused artery : roles of VLDL and HDL. Circ Res (2000) 1.67
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med (2014) 1.60
Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study. Clin Chem (2014) 1.59
Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization. Nat Genet (2013) 1.54
Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J (2014) 1.51
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51
Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions. J Lipid Res (2007) 1.44
Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change. PLoS Med (2014) 1.42
Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol (1997) 1.33
A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates. Nat Commun (2013) 1.32
Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol (2011) 1.32
Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet (2015) 1.32
Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation (2015) 1.25
Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions. J Lipid Res (2010) 1.21
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. Nat Commun (2014) 1.18
Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia. J Lipid Res (2010) 1.15
Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium. PLoS One (2013) 1.02
Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production. Curr Opin Lipidol (2012) 0.93
Regulation of chylomicron production in humans. Biochim Biophys Acta (2011) 0.92
Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler Thromb (1991) 0.91
Application of statistical and functional methodologies for the investigation of genetic determinants of coronary heart disease biomarkers: lipoprotein lipase genotype and plasma triglycerides as an exemplar. Hum Mol Genet (2010) 0.87